BSE filing, NSE: DELHIVERY. Summary written from the filing by ALFA Finder's alert engine.
Delhivery Ltd: key numbers
- Share price
- ₹385.00
- Market cap
- ₹28,857 Cr
- Revenue (annual)
- ₹10,508 Cr
- Net profit (annual)
- ₹152.7 Cr
- P/E (TTM)
- 308.5×Sector 30.1×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 39.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Delhivery Ltd
All →Delhivery Board Meeting Date
Delhivery Limited will hold a board meeting on October 30, 2026, to approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Delhivery Business Update
Delhivery won the Golden Peacock Award for Excellence in Corporate Governance 2026 in the Logistics sector. The recognition was awarded by the Institute of Directors, India.
Delhivery Employee Stock Options
Delhivery Ltd allotted 2,28,116 equity shares upon the exercise of vested stock options under its ESOP plans. The allotment increases the company's paid-up share capital.
- Value
- ₹0.07 Cr
Delhivery Employee Stock Options
Delhivery Ltd has granted 52,600 stock options to eligible employees under its ESOP 2012 plan. This action is part of the company's ongoing employee incentive scheme.
Delhivery Employee Stock Options
Delhivery Limited has granted 9,00,000 stock options under its ESOP-2021 plan. The options are exercisable at Re. 1 per share subject to vesting conditions.
Delhivery Annual General Meeting
Delhivery Limited held its 15th Annual General Meeting on September 22, 2026, via video conferencing to transact various ordinary and special business resolutions.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.